NFKB1 and prostate carcinoma: There are some transcriptional factors, such as AP-1, CCAAT enhancer binding protein, cAMP response element binding protein, as well as NF-κB reported to have potential binding sites within the human IL-6 gene promoter area and, thus, could interfere IL-6 gene expression in prostate cancer cells [21], [36].